# Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

> **NCT06431789** · — · RECRUITING · sponsor: **Yi Han** · enrollment: 220 (estimated)

## Conditions studied

- Gene Polymorphism
- Edoxaban
- Renal Insufficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06431789
- **Lead sponsor:** Yi Han
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-04-30
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2024-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06431789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06431789, "Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06431789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*